Characterization of Two Mutations Associated with Epimerase-Deficiency Galactosemia, by Use of a Yeast Expression System for Human UDP-Galactose-4-Epimerase-Reference-Cited by-同舟云学术

Characterization of Two Mutations Associated with Epimerase-Deficiency Galactosemia, by Use of a Yeast Expression System for Human UDP-Galactose-4-Epimerase

Published:1997-09 Issue:3 Volume:61 Page:590-598
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Quimby B.B.,Alano A.,Almashanu S.,DeSandro A.M.,Cowan T.M.,Fridovich-Keil J.L.

Publisher

Elsevier BV

Subject

Genetics(clinical),Genetics

Reference39 articles.

1. A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains;Alani;Genetics,1987

2. UDP-galactose-4-epimerase deficiency among African-Americans: evidence for multiple alleles;Alano;J Invest Med,1997

3. Use of cyclosporin A in establishing Epstein-Barr virus transformed human lymph-oblastoid cell lines;Anderson;In Vitro,1984

4. Uridine diphosphate galastose 4-epimerase in human and other mammalian hemolysates;Bergren;Biochim Biophys Acta,1973

5. Red cell metabolism: a manual of biochemical methods;Beutler,1975

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations;Human Molecular Genetics;2023-04-03

2. GALE variants associated with syndromic manifestations, macrothrombocytopenia, bleeding, and platelet dysfunction;Platelets;2023-02-27

3. A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations;2022-05-25

4. Molecular dynamics, residue network analysis, and cross-correlation matrix to characterize the deleterious missense mutations in GALE causing galactosemia III;Cell Biochemistry and Biophysics;2021-02-08

5. Galactosemia: opportunities for novel therapies;Protein Homeostasis Diseases;2020